135 related articles for article (PubMed ID: 14594107)
21. Somatostatin, cortistatin, ghrelin and glucose metabolism.
Gauna C; van der Lely AJ
J Endocrinol Invest; 2005; 28(11 Suppl International):127-31. PubMed ID: 16625861
[TBL] [Abstract][Full Text] [Related]
22. Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma.
Grottoli S; Gasco V; Broglio F; Baldelli R; Ragazzoni F; Gallenca F; Mainolfi A; Prodam F; Muccioli G; Ghigo E
J Clin Endocrinol Metab; 2006 Apr; 91(4):1595-9. PubMed ID: 16449338
[TBL] [Abstract][Full Text] [Related]
23. Cortistatin and pituitary hormone secretion in rat.
Baranowska B; Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L
J Physiol Pharmacol; 2009 Mar; 60(1):151-6. PubMed ID: 19439817
[TBL] [Abstract][Full Text] [Related]
24. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
[TBL] [Abstract][Full Text] [Related]
25. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
[TBL] [Abstract][Full Text] [Related]
26. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
[TBL] [Abstract][Full Text] [Related]
27. Direct effect of cortistatin on GH release from cultured pituitary cells in the rat.
Baranowska B; Chmielowska M; Wolinska-Witort E; Bik W; Baranowska-Bik A; Martynska L
Neuro Endocrinol Lett; 2006; 27(1-2):153-6. PubMed ID: 16648801
[TBL] [Abstract][Full Text] [Related]
28. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.
Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F
Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585
[TBL] [Abstract][Full Text] [Related]
29. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland.
Deghenghi R; Papotti M; Ghigo E; Muccioli G
J Endocrinol Invest; 2001 Jan; 24(1):RC1-3. PubMed ID: 11227737
[TBL] [Abstract][Full Text] [Related]
30. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans.
Broglio F; Arvat E; Benso A; Gottero C; Muccioli G; Papotti M; van der Lely AJ; Deghenghi R; Ghigo E
J Clin Endocrinol Metab; 2001 Oct; 86(10):5083-6. PubMed ID: 11600590
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone-inhibiting activity of cortistatin in the rat.
Deghenghi R; Avallone R; Torsello A; Muccioli G; Ghigo E; Locatelli V
J Endocrinol Invest; 2001 Dec; 24(11):RC31-3. PubMed ID: 11817718
[TBL] [Abstract][Full Text] [Related]
32. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
[TBL] [Abstract][Full Text] [Related]
33. Cortistatin is not a somatostatin analogue but stimulates prolactin release and inhibits GH and ACTH in a gender-dependent fashion: potential role of ghrelin.
Córdoba-Chacón J; Gahete MD; Pozo-Salas AI; Martínez-Fuentes AJ; de Lecea L; Gracia-Navarro F; Kineman RD; Castaño JP; Luque RM
Endocrinology; 2011 Dec; 152(12):4800-12. PubMed ID: 21971153
[TBL] [Abstract][Full Text] [Related]
34. The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children.
Bellone J; Bellone S; Aimaretti G; Valetto MR; Baffoni C; Corneli G; Origlia C; Arvat E; Ghigo E
J Endocrinol Invest; 2000 Mar; 23(3):158-62. PubMed ID: 10803472
[TBL] [Abstract][Full Text] [Related]
35. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.
Cassoni P; Allia E; Marrocco T; Ghè C; Ghigo E; Muccioli G; Papotti M
J Endocrinol Invest; 2006 Oct; 29(9):781-90. PubMed ID: 17114908
[TBL] [Abstract][Full Text] [Related]
36. Oestrogen replacement does not restore the reduced GH-releasing activity of Hexarelin, a synthetic hexapeptide, in post-menopausal women.
Arvat E; Gianotti L; Broglio F; Maccagno B; Bertagna A; Deghenghi R; Camanni F; Ghigo E
Eur J Endocrinol; 1997 May; 136(5):483-7. PubMed ID: 9186268
[TBL] [Abstract][Full Text] [Related]
37. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma.
Arvat E; Giordano R; Ramunni J; Arnaldi G; Colao A; Deghenghi R; Lombardi G; Mantero F; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 Dec; 83(12):4207-11. PubMed ID: 9851753
[TBL] [Abstract][Full Text] [Related]
38. Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients.
Grottoli S; Arvat E; Gauna C; Maccagno B; Ramunni J; Giordano R; Maccario M; Deghenghi R; Ghigo E
Int J Obes Relat Metab Disord; 2000 Jun; 24 Suppl 2():S136-7. PubMed ID: 10997633
[TBL] [Abstract][Full Text] [Related]
39. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E
J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
[TBL] [Abstract][Full Text] [Related]
40. Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans.
Bisi G; Podio V; Valetto MR; Broglio F; Bertuccio G; Del Rio G; Arvat E; Boghen MF; Deghenghi R; Muccioli G; Ong H; Ghigo E
J Endocrinol Invest; 1999 Apr; 22(4):266-72. PubMed ID: 10342360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
